Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma
Galina Lagos, Roman Groisberg, Andrew Elliott, et al.
The Oncologist
|
July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study
Richard F Riedel, Karla V Ballman, Yao Lu, et al.
Genomics
|
May 20, 1999
A genome-wide search for linkage to asthma. German Asthma Genetics Group
M Wjst, G Fischer, T Immervoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma
Scott M Schuetze, Karla V Ballman, Rachel Heise, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy
George D Demetri, Sant P Chawla, Isabelle Ray-Coquard, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2020
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Emily Z Keung, Melissa Burgess, Ruth Salazar, et al.
The Lancet. Oncology
|
October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma
Galina Lagos, Roman Groisberg, Andrew Elliott, et al.
The Oncologist
|
July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study
Richard F Riedel, Karla V Ballman, Yao Lu, et al.
Genomics
|
May 20, 1999
A genome-wide search for linkage to asthma. German Asthma Genetics Group
M Wjst, G Fischer, T Immervoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2021
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sant P Chawla, Brian A Van Tine, Seth M Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma
Scott M Schuetze, Karla V Ballman, Rachel Heise, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy
George D Demetri, Sant P Chawla, Isabelle Ray-Coquard, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2020
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Emily Z Keung, Melissa Burgess, Ruth Salazar, et al.
The Lancet. Oncology
|
October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Page
of 22